This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Virginia Tech Intellectual Properties Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joseph Michael Salamoun: Innovator in Mitochondrial Uncoupling Compounds
Introduction
Joseph Michael Salamoun is a notable inventor based in Roanoke, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as mitochondrial uncouplers. His work aims to address various health conditions by targeting mitochondrial functions.
Latest Patents
Joseph Michael Salamoun holds a patent for "Oxadiazolopyrazines and oxadiazolopyridines useful as mitochondrial uncouplers." This patent describes compounds of Formula I and their pharmaceutically acceptable salts. The compounds are designed to act as selective mitochondrial protonophore uncouplers that do not affect the plasma membrane potential. They are useful for treating or decreasing the risk of conditions such as cancer, obesity, type II diabetes, fatty liver disease, insulin resistance, Parkinson's disease, ischemia reperfusion injury, heart failure, non-alcoholic fatty liver disease (NALFD), and non-alcoholic steatohepatitis (NASH). Additionally, these compounds can help increase lifespan by decreasing the production of reactive oxygen species (ROS), which contribute to age-related cell damage.
Career Highlights
Joseph Michael Salamoun is associated with Virginia Tech Intellectual Properties Inc., where he continues to innovate and develop new pharmaceutical solutions. His work has the potential to significantly impact the treatment of various metabolic and age-related diseases.
Collaborations
Some of his notable coworkers include Webster L Santos and Jacob H Murray, who contribute to the collaborative efforts in research and development within the organization.
Conclusion
Joseph Michael Salamoun's innovative work in mitochondrial uncoupling compounds showcases his commitment to advancing medical science and improving health outcomes. His contributions are paving the way for new treatments that could benefit many individuals facing serious health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile